Renalytix plc CEO James McCullough's 2024 pay falls 25% to $780K

Renalytix plc reports 2024 executive compensation

By ExecPay News

Published: November 25, 2024

Renalytix plc reported fiscal year 2024 executive compensation information on November 25, 2024.
In 2024, five executives at Renalytix plc received on average a compensation package of $563K, a 27% decrease compared to previous year.
Average pay of disclosed executives at Renalytix plc
James McCullough, Chief Executive Officer, received $780K in total, which decreased by 25% compared to 2023. 65% of McCullough's compensation, or $510K, was in salary. McCullough also received $242K in option awards and $29K in other compensation.
Thomas McLain, Prior President, received a compensation package of $762K, which increased by 15% compared to previous year. 55% of the compensation package, or $421K, was in salary.
O. James Sterling, Chief Financial Officer, earned $467K in 2024, a 25% decrease compared to previous year.
Fergus Fleming, Chief Technology Officer, received $426K in 2024.
Michael J. Donovan, Chief Medical Officer, earned $380K in 2024.
Renalytix plc's fiscal year ends on June 30.

Related executives

James McCullough

Renalytix plc

Chief Executive Officer

Fergus Fleming

Renalytix plc

Chief Technology Officer

Michael Donovan

Renalytix plc

Chief Medical Officer

Thomas McLain

Renalytix plc

Prior President

O Sterling

Renalytix plc

Chief Financial Officer

You may also like

Source: SEC filing on November 25, 2024.